Tel: 01789 267520

Latest News: Research

Biogen Releases Statement on CHERISH Data and Plans for New Clinical Research

21 February 2018 / Posted in: Research

Biogen has provided a community statement on the final results from CHERISH, a Phase 3 study of SPINRAZA.

Read full story

Are you Willing to Talk to the Media About your Experience of SMA and Access to Nusinersen?

16 February 2018 / Posted in: Research

As part of our ‘working together for access to nusinersen’, MDUK is managing our media contact & would like to hear from you. You'd be fully supported by a member of the MDUK media team through the interview process, & you'd get to choose which media you're happy to speak to.

Read full story

Are you Affected by SMA Type 1 and Willing to Share your Experience with TreatSMA?

16 February 2018 / Posted in: Research

As part of our ‘working together for access to nusinersen’, TreatSMA is gathering people’s experiences to present to NICE. If you are willing to take part, please click here to find out more.

Read full story

Rare Disease Day – 28th February 2018

14 February 2018 / Posted in: Research

Taking place each year on the last day in February, the main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients' lives.

Read full story

Map the Gap Campaign

14 February 2018 / Posted in: Research

Part of the larger initiative, The GenomeAsia100K project, Map the Gap aims to sequence 100 South Asian Genomes, enabling the development of carrier tests, diagnosis, and treatment for rare diseases, cancers, and diabetes.

Read full story

Opportunity to let NICE hear your views about the impact of 5q SMA and who should be able to access nusinersen

12 February 2018 / Posted in: Research

SMA Support UK has set up a number of surveys so that we can collect different people’s views and share them with MDUK, SMA Trust, TreatSMA, and NICE. Deadline to complete survey(s) is 18th Feb.

Read full story

Our Patient Group Submission to the Scottish Medicines Consortium (SMC)

06 February 2018 / Posted in: Research

Thanks to those who responded to our invitation to take part in a survey to tell us about your experiences of SMA and your views on access to nusinersen. Read a copy of our submission and a summary of the survey results, here.

Read full story

Rare Disease Implementation Plans for England Published

01 February 2018 / Posted in: Information & Support, Research

The Department of Health and Social Care and NHS England have published their implementation plans for the UK Strategy for Rare Diseases. England is now in line with Scotland, Wales and Northern Ireland who already have plans in place.

Read full story

AveXis Announce Additional Trials of AVXS-101 for SMA

25 January 2018 / Posted in: Research

AveXis have provided an overview of their expanded program of clinical development for their gene therapy drug AVXS-101 in SMA, which incorporates two new trials to include a broader set of SMA patients.

Read full story

Biogen’s SMA Community Update Confirms the NICE Appraisal Process

22 January 2018 / Posted in: Research

It also contains a little bit more information about how the possibility of a Managed Access Programme will be explored.

Read full story